876
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluations

Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma

, , &
Pages 1517-1527 | Published online: 21 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yan Li, Liangang Liu, Lian Huang, Xiaomin Wang, Matthew Hoffmann, Josephine Reyes, Maria Palmisano & Simon Zhou. (2018) A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension. Clinical Pharmacology: Advances and Applications 10, pages 89-99.
Read now
Roberto Mina, Mattia D’Agostino, Chiara Cerrato, Francesca Gay & Antonio Palumbo. (2017) Plasma cell leukemia: update on biology and therapy. Leukemia & Lymphoma 58:7, pages 1538-1547.
Read now
Joseph Abraham, Noha N. Salama & Abdel Kareem Azab. (2015) The role of P-glycoprotein in drug resistance in multiple myeloma. Leukemia & Lymphoma 56:1, pages 26-33.
Read now
Anna Guidetti, Claudia Paba Prada, Jacob P Laubach, Cindy Varga, Michelle E Maglio, Mary McKenney, Deborah Doss, Robert L Schlossman, Constantine Mitsiades, Teru Hideshima, Güllü T Görgün, Irene M Ghobrial, Noopur Raje, Nikhil Munshi, Kenneth C Anderson & Paul G Richardson. (2014) Pomalidomide for the treatment of relapsed and refractory multiple myeloma. Expert Opinion on Orphan Drugs 2:10, pages 1089-1108.
Read now

Articles from other publishers (12)

Nelson Leung & S. Vincent Rajkumar. (2023) Multiple myeloma with acute light chain cast nephropathy. Blood Cancer Journal 13:1.
Crossref
Robert Z. Orlowski. 2023. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies 301 312 .
Yannan Wang, Sisi Lin, Ying Wang & Zhuoyan Wang. (2022) Bioequivalence of Pomalidomide Capsules in Fasting and Fed States in Healthy Male Volunteers: A Randomized, Open, Single‐Dose, Biperiodic, Double‐Crossover Study. Clinical Pharmacology in Drug Development 11:11, pages 1246-1252.
Crossref
S. V. Semochkin. (2022) Mechanisms of action of immunomodulatory drugs — from teratogenicity to treatment of multiple myeloma. Russian journal of hematology and transfusiology 67:2, pages 240-260.
Crossref
Despina Fotiou, Maria Gavriatopoulou, Evangelos Terpos & Meletios A. Dimopoulos. (2022) Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma. Therapeutic Advances in Hematology 13, pages 204062072210900.
Crossref
Jason Fangusaro, Duane A. Mitchell, Mehmet Kocak, Giles W. Robinson, Patricia Ann Baxter, Eugene I. Hwang, Jianping Huang, Arzu Onar‐Thomas, Ira J. Dunkel, Maryam Fouladi & Katherine E. Warren. (2020) Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial. Pediatric Blood & Cancer 68:2.
Crossref
Kathleen W. Zhang, Keith E. Stockerl-Goldstein & Daniel J. Lenihan. (2019) Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis. JACC: Basic to Translational Science 4:3, pages 438-448.
Crossref
Yan Li, Xiaomin Wang, Liangang Liu, Chengyue Zhang, Diana Gomez, Josephine Reyes, Maria Palmisano & Simon Zhou. (2018) An Open‐Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide Pharmacokinetics. Clinical Pharmacology in Drug Development 8:3, pages 346-354.
Crossref
Yan Li, Liangang Liu, Xiaomin Wang, Chengyue Zhang, Josephine Reyes, Matthew Hoffmann, Maria Palmisano & Simon Zhou. (2018) In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects. The Journal of Clinical Pharmacology 58:10, pages 1295-1304.
Crossref
Kim Dao, Haithem Chtioui, Yimin Lu, Cody J. Peer, William D. Figg, Menno Pruijm, Thierry Buclin & Sébastien Kissling. (2017) Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High-Cutoff Filter. American Journal of Kidney Diseases 69:4, pages 553-554.
Crossref
Cyrille Touzeau & Philippe Moreau. (2016) Pomalidomide in the management of relapsed multiple myeloma. Future Oncology 12:17, pages 1975-1983.
Crossref
Divisha Raheja, Charles Specht & Zachary Simmons. (2015) Paraproteinemic neuropathies. Muscle & Nerve 51:1, pages 1-13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.